Covered recipient · General Payments record
BANKIM ASHOK BHATT
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2025
$12,384.39
- Reported across 63 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,096.88 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $365.85 | 9 |
| Sequel Med Tech, LLC | $140.40 | 2 |
| KYOWA KIRIN, INC. | $126.46 | 1 |
| Lilly USA, LLC | $124.00 | 1 |
| Medtronic, Inc. | $121.82 | 1 |
| BETA BIONICS, INC. | $102.05 | 1 |
| DEXCOM, INC. | $45.57 | 1 |
| Insulet Corporation | $35.98 | 1 |
| Novo Nordisk AS | $34.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $124.74 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228539023 | CMS |
| Amgen Inc. | $3.68 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227123175 | CMS |
| Amgen Inc. | $0.92 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227123173 | CMS |
| Amgen Inc. | $6.31 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227123177 | CMS |
| Amgen Inc. | $6.43 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227123179 | CMS |
| Amgen Inc. | $4.14 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227123171 | CMS |
| Amgen Inc. | $117.82 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228539027 | CMS |
| Amgen Inc. | $99.66 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228539029 | CMS |
| Amgen Inc. | $2.15 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227123169 | CMS |
| BETA BIONICS, INC. | $102.05 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246809152 | CMS |
| Dexcom, Inc. | $45.57 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250472430 | CMS |
| Insulet Corporation | $35.98 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207064751 | CMS |
| KYOWA KIRIN, INC. | $126.46 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222074999 | CMS |
| Lilly USA, LLC | $124.00 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186528323 | CMS |
| Medtronic, Inc. | $121.82 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218849929 | CMS |
| Novo Nordisk Inc | $34.75 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188749698 | CMS |
| Sequel Med Tech, LLC | $126.52 | 09/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243731233 | CMS |
| Sequel Med Tech, LLC | $13.88 | 09/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243731238 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.